Litcius/Paper detail

Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: a case report

Se Il Kim, Hung Youl Seok, Jaehyuck Yi, Jang Hyuk Cho

2021Journal of International Medical Research23 citationsDOIOpen Access PDF

Abstract

The ongoing global administration of vaccines for coronavirus disease 2019 (COVID-19) means that increasing numbers of patients are likely to present with post-vaccination complications. We describe the first reported case of neuralgic amyotrophy (NA) involving the lumbosacral plexus occurring after AstraZeneca COVID-19 vaccination. The patient presented with acute-onset leg paralysis following administration of the vaccine. Based on the clinical, electrodiagnostic, and radiologic findings, the patient was diagnosed with post-vaccination NA. We speculate that the COVID-19 vaccine elicited an immune-mediated inflammatory response to the injected antigen due to inflammatory immunity in a patient with predisposed susceptibility to NA.

Topics & Concepts

MedicineVaccinationLumbosacral jointCoronavirus disease 2019 (COVID-19)ParalysisSurgeryDiseaseInternal medicineImmunologyInfectious disease (medical specialty)Peripheral Nerve DisordersOrthopedic Surgery and RehabilitationPeripheral Neuropathies and Disorders
Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: a case report | Litcius